Cargando…

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin

Diabetic ketoacidosis is characterized by hyperglycemia, anion-gap acidosis, and increased plasma ketones. After the resolution of hyperglycemia, persistent diuresis is rare. We herein report the case of a 27-year-old Asian woman with type 2 diabetes who was treated with a sodium-glucose cotransport...

Descripción completa

Detalles Bibliográficos
Autores principales: Adachi, Junichiro, Inaba, Yuusuke, Maki, Chisato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337465/
https://www.ncbi.nlm.nih.gov/pubmed/28090050
_version_ 1782512382959943680
author Adachi, Junichiro
Inaba, Yuusuke
Maki, Chisato
author_facet Adachi, Junichiro
Inaba, Yuusuke
Maki, Chisato
author_sort Adachi, Junichiro
collection PubMed
description Diabetic ketoacidosis is characterized by hyperglycemia, anion-gap acidosis, and increased plasma ketones. After the resolution of hyperglycemia, persistent diuresis is rare. We herein report the case of a 27-year-old Asian woman with type 2 diabetes who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (canagliflozin) who developed euglycemic diabetic ketoacidosis and persistent diuresis in the absence of hyperglycemia. Physicians should consider euglycemic diabetic ketoacidosis in the differential diagnosis of patients treated with SGLT2 inhibitors.
format Online
Article
Text
id pubmed-5337465
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-53374652017-03-08 Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin Adachi, Junichiro Inaba, Yuusuke Maki, Chisato Intern Med Case Report Diabetic ketoacidosis is characterized by hyperglycemia, anion-gap acidosis, and increased plasma ketones. After the resolution of hyperglycemia, persistent diuresis is rare. We herein report the case of a 27-year-old Asian woman with type 2 diabetes who was treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor (canagliflozin) who developed euglycemic diabetic ketoacidosis and persistent diuresis in the absence of hyperglycemia. Physicians should consider euglycemic diabetic ketoacidosis in the differential diagnosis of patients treated with SGLT2 inhibitors. The Japanese Society of Internal Medicine 2017-01-15 /pmc/articles/PMC5337465/ /pubmed/28090050 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Adachi, Junichiro
Inaba, Yuusuke
Maki, Chisato
Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title_full Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title_fullStr Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title_full_unstemmed Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title_short Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
title_sort euglycemic diabetic ketoacidosis with persistent diuresis treated with canagliflozin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337465/
https://www.ncbi.nlm.nih.gov/pubmed/28090050
work_keys_str_mv AT adachijunichiro euglycemicdiabeticketoacidosiswithpersistentdiuresistreatedwithcanagliflozin
AT inabayuusuke euglycemicdiabeticketoacidosiswithpersistentdiuresistreatedwithcanagliflozin
AT makichisato euglycemicdiabeticketoacidosiswithpersistentdiuresistreatedwithcanagliflozin